Nasdaq approved the listing of Canary’s proposed ETF tracking the INJ token from Injective. The fund would stake at least 90% of its INJ holdings to generate yield. Canary would charge an annual sponsor fee of 1.10%.
Source: Read the original article
Disclaimer: this content is for information purposes only and is not financial advice. Cryptocurrencies are highly volatile: you may lose all of your capital. Always do your own research. Legal notice
